NESTcc will have several panel opportunities at the ISPOR 23rd Annual International Meeting. NESTcc Executive Director Rachael Fleurence, PhD will moderate the following sessions:

  • May 21, 2018 (8:30a.m. – 10:30a.m.) Plenary Session: Inflection Point for Real-World Evidence? The Transformational Role of Digital Health
  • May 21, 2018 (2:15p.m. – 3:15p.m.) Spotlight Session: Reinventing the Future of Knowledge Generation In Healthcare
  • May 21, 2018 (5:00p.m. – 6:00p.m.) NESTcc Issue Panel: The Changing Landscape of Health Care Decision-Making – How can we Leverage the use of Real-World Evidence for Regulatory, Coverage, and Clinical Decision-Making?
  • May 22, 2018 (6:15p.m. – 7:15p.m.) ISPOR Forum: Value of Information (VOI) Analysis for Research Decisions Emerging Good Practices Task Force: Final Recommendations


Rachael Fleurence, PhD
Executive Director,

Owen Faris, PhD
Clinical Trials Director, Office of Device Evaluation, Center for Devices and Radiological Health
U.S. Food and Drug Administration

Kathleen Blake, MD, MPH
Vice President, Healthcare Quality,
American Medical Association (AMA)

Naomi Aronson, PhD
Executive Director of Clinical Evaluation, Innovation, and Policy
Blue Cross and Blue Shield Association


Baltimore Convention Center
1 W Pratt St.
Baltimore, MD 21201


Register for ISPOR Baltimore

← Back